Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics Appoints Dr. Miguel Forte As CEO

Dec 19 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS ANNOUNCES THE APPOINTMENT OF DR.
MIGUEL
FORTE AS CEO TO LEAD THE COMPANY INTO THE NEXT PHASE OF
DEVELOPMENT
    * BONE THERAPEUTICS - DR. FORTE SUCCEEDS THOMAS LIENARD WHO
LEAVES
COMPANY IN COMMON AGREEMENT WITH BOARD OF DIRECTORS
    * BONE THERAPEUTICS THOMAS WILL REMAIN AVAILABLE TO COMPANY
FOR 6
MONTHS TO SUPPORT SUCCESSION DURING TRANSITION PERIOD.
    * APPOINTMENT OF DR. MIGUEL FORTE AS CHIEF EXECUTIVE
OFFICER,
EFFECTIVE 1 JANUARY 2020

Source text for Eikon:  ID:nGNE4gWSkH 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Biosenic SA

See all news